Compounds > amifampridine
Page last updated: 2024-11-08

amifampridine and Carcinoma, Squamous Cell

amifampridine has been researched along with Carcinoma, Squamous Cell in 2 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shipley, E1
Krim, E1
Deminière, C1
Lagueny, A1
Tim, RW1
Massey, JM1
Sanders, DB1

Other Studies

2 other studies available for amifampridine and Carcinoma, Squamous Cell

ArticleYear
[Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma].
    Revue neurologique, 2008, Volume: 164, Issue:1

    Topics: 4-Aminopyridine; Amifampridine; Carcinoma, Squamous Cell; Cholinesterase Inhibitors; Electrophysiolo

2008
Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.
    Neurology, 2000, Jun-13, Volume: 54, Issue:11

    Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Aged, 80 and over; Amifampridine; Carcinoma, Small Cell; C

2000